Empire Genomics
Edit Page
Report
Scan day: 06 February 2014 UTC
25
Virus safety - good
Description: Diagnostics company providing analysis of FGFR2 gene that have been associated with several medical conditions including Breast Cancer, Apert Syndrom, and Jackson-Weiss Syndrome. Provides information about the company, diagnostic assays, and services.
Empire Genomics | Enabling Personalized Medicine Empire Genomics - Enabling Personalized Medicine New Products & Services Empire Genomics (EG) is a molecular diagnostics company that develops and offers a comprehensive menu of assay services for use in diagnosing and guiding precise therapeutic treatments for patients. The EG services are designed to specifically meet the needs of pathologists, oncologists and researchers. Our mission is to address the problem the medical community faces with the rapid pace of molecular technology innovations, and the need for the delivery of clinically relevant, cost effective patient decision support tools. Ultimately, through our continued growth customers will be able to realize: faster and more effective drug development, lower healthcare costs, and better clinical outcomes for patients. Empire is uniquely positioned to bring this innovative service to the medical community through its highly qualified team, state of the art facilities and key strategic partnerships with leaders in the global research community. We are a resource to make personalized medicine a reality for you.
Size: 1141 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Empire Genomics | Enabling Personalized Medicine |
| Keywords: | |
| Description: | |
| IP-address: | 173.203.222.59 |
WHOIS Info
| NS | Name Server: NS20.NETRIPLEX.COM Name Server: NS21.NETRIPLEX.COM Name Server: NS22.NETRIPLEX.COM Name Server: NS23.NETRIPLEX.COM |
| WHOIS | Status: clientDeleteProhibited Status: clientRenewProhibited Status: clientTransferProhibited Status: clientUpdateProhibited |
| Date | Creation Date: 24-jan-2006 Expiration Date: 24-jan-2015 |